There are several point-of-care testing devices available for rapid haematocrit (Hct) or haemoglobin (Hb) concentration determination 1 . One such device is the i-STAT ® (Abbott Point of Care Inc., Princeton, NJ, USA), a portable handheld point-of-care testing (POCT) device. The i-STAT ® uses disposable cartridges, filled with approximately 65 µl of blood, and measures Hct via a conductometric method in less than two minutes. The measured Hct value is then converted to a derived Hb measurement by a simple proportionality constant (Hb (g/dl)=Hct (% packed cell volume) x 0.34) 2 . The i-STAT ® also measures other analytes for blood gas analysis and various electrolytes. The characteristic results for these analyses are not discussed in this paper.
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Conductometry is a measurement of current in a solution when a constant potential difference is applied. Current (conductivity) is inversely related to the resistance (current = potential/resistance). Erythrocytes are electrical insulators due to their lipid membrane and will increase resistance, hence decreasing the conductivity (current) of whole blood. Whole blood conductivity depends on the volume fraction of erythrocytes (Hct), shape of erythrocytes and the surrounding plasma. The shape of erythrocytes and plasma conductivity are assumed to be constant when calculating conductivity 3 . Hence, Hct can be calculated based on the conductivity of whole blood. Hct measured via the conductometric method can also be affected by variations in sodium and potassium concentrations, abnormal plasma protein levels, elevated white blood cell counts, abnormal lipid levels and improper sample collection and handling 1,2 .
SUMMARY
We investigated the accuracy of i-STAT ® (Abbott Point of Care Inc., Princeton, NJ, USA) haemoglobin (Hb) measurement in surgical patients with an estimated blood loss of ≥25% of total blood volume. Blood tests for i-STAT ® Hb, laboratory Hb (Sysmex XE-2100™, Sysmex Corporation, Kobe, Japan) and total plasma proteins were obtained at the start of surgery (T=0) and when an estimated 25% total blood volume loss had occurred (T=1). Thirty-one patients were recruited. The coefficient of variation of the paired i-STAT Hb estimates was 2.8% and 2.9% at T=0 and T=1, respectively. The mean difference between i-STAT ® and laboratory Hb was -7.6 g/l (standard deviation 6.5) at T=0 and -5.1 g/l (standard deviation 12) at T=1. The mean total plasma protein difference (total plasma protein T=0 minus T=1) was 13.6 g/l (95% confidence interval 10.2 to 17.0). There was poor correlation between total plasma protein and bias in i-STAT ® measurements. The i-STAT ® Hb had an acceptable coefficient of variation, but the Hb levels were lower than those estimated by the laboratory. The standard deviation of i-STAT ® Hb was greater after ≥25% estimated total blood volume loss. Clinicians should not use the i-STAT ® Hb in isolation for clinical decision-making when considering blood transfusion in a situation of 25% or greater blood loss.
The idea behind a portable handheld device is to enable rapid assessment of blood results, allowing rapid clinical decision-making. In order for this clinical advantage of POCT to be realised, the system must have the characteristics of accuracy (accuracy of a measurement device is defined as the ability of a measurement to match the actual value of the quantity being measured), precision (in this study, precision of a measurement device was defined as the ability of the device to measure consistently) and reliability (reliability of a measurement device was defined as its ability to yield the same results under different clinical conditions) 4, 5 .
Multiple studies have evaluated the i-STAT ® POCT device [6] [7] [8] [9] [10] [11] [12] [13] [14] . These studies show different results concerning the accuracy of i-STAT ® derived Hct. Three studies concluded that i-STAT ® POCT was accurate 9, 11, 13 . In contrast, there were five studies that concluded that i-STAT ® POCT was inaccurate [6] [7] [8] 10, 12, 14 . There were two i-STAT ® POCT-related papers that suggested that the inaccuracy of Hct measurement was due to a change in plasma protein levels 6, 7 .
After major blood loss, plasma protein levels will decrease, and this is one of the factors that may affect i-STAT ® -measured Hct and calculated Hb 15 . There are currently no clinical trials in the literature that study this effect. In this study, we investigated the accuracy of the i-STAT ® -calculated Hb during major blood loss and whether the bias in accuracy, if any, was correlated to the change in total plasma protein.
METHODS
Institutional ethics approval was obtained prior to commencement of the study (NTX 06/04/040). The need for patient consent was waived because this was a non-interventional laboratory-based study of samples taken as a part of routine clinical care.
All adult patients presenting for a surgical procedure with an estimated blood loss of ≥25% of their total blood volume and in whom an arterial line was part of their standard of care were eligible. Total blood volume (TBV) was estimated with a simple formula: TBV=weight (kg) x 70 ml/kg. Patients with preoperative hypoalbuminemia or anticipated albumin transfusion as part of anaesthetic management were excluded from the study.
Patients were recruited after being assessed for suitability by the anaesthetist doing the case. An arterial blood sample was taken pre-incision for full blood count, total plasma protein concentration and two i-STAT ® measurements using separate cartridges. The samples for full blood count and total plasma protein were immediately sent to the laboratory for testing. All point-of-care testing was done as soon as possible after drawing the blood sample.
The laboratory Hb was analysed via the Coulter counter method using the Sysmex XE-2100™ analyser (Sysmex Corporation, Kobe, Japan). Total plasma protein was analysed using colorimetric assay of the COBAS INTEGRA ® system, which is part of the Roche/Hitachi modular analyser (Roche Diagnostics, Mannheim, Germany). The colorimetric assay involves the binding of divalent copper to protein peptide, which results in a characteristic purplecoloured biuret complex. The colour intensity of this complex is proportional to protein concentration and is determined by measuring its absorbance at 552 nm 18 . i-STAT ® CG8+ cartridges were used for this study.
Anaesthetic and fluid management were at the discretion of the anaesthetist. When an estimated blood loss of ≥25% of a patient's TBV occurred, as determined by the primary anaesthetist, another similar set of blood samples was taken for analysis. No blood transfusion was initiated prior to the second set of blood samples. The primary anaesthetist estimated blood loss clinically, via visual inspection of soaked swabs, blood collected in suction bottles and blood on the surgical table or around the patient.
Patients who were initially recruited and who did not lose ≥25% of their TBV were excluded from the study. Patients were also excluded if they received an albumin infusion during surgery.
Statistics
A sample size of 30 would enable a bias equating to an effect size of approximately 0.5 to be detected as statistically significant (two-tailed α=0.05) with 80% power. An effect size of 0.5 in this context is approximately a bias in the preoperative Hb measurement of 3.5 g/l. All statistical calculations were performed on Microsoft Excel software (Redmond, WA, USA) and R version 2.15.2 (The R Foundation for Statistical Computing, Vienna, Austria). The average of two i-STAT ® Hb measurments was used in all calculations except for calculating precision.
To allow assessment of precision of the i-STAT ® device, coefficient of variation (CV) of duplicate i-STAT ® measurements was used.
Accuracy of the i-STAT ® POCT device was assessed by comparing the mean difference between the paired i-STAT ® and laboratory Hb measurements at T=0 and T=1.
The precision and accuracy of the i-STAT ® POCT device was assessed visually using Bland-Altman plots and statistically by calculating the limits of agreement 16 at T=0 and T=1. We used the laboratory Hb measurement on the x axis of the plots as, in this situation, this was accepted as being the reference standard 17 .
The relationship between total plasma protein concentration and accuracy of the device was assessed using Spearman's correlation coefficients.
RESULTS
Thirty-one patients (n=31) were recruited from a range of surgical specialties from July 2006 to September 2007 ( Table 1 ). The age of patients ranged from 14 to 88 years (mean 62), and the weight of patients ranged from 48 to 120 kg (mean 76). As a consequence of incomplete data, a dataset of 30 was used for the Bland-Altman plots and a dataset of 28 was used for Spearman's correlation coefficient analyses.
Precision
The mean paired i-STAT ® CVs at the start of surgery (T=0) and after ≥25% TBV loss (T=1) were 2.8% and 2.9%, respectively.
Accuracy and reliability
The mean difference and limits of agreement between i-STAT ® Hb and laboratory Hb at T=0 was -7.6 g/l ±2SD (standard deviation of 13 (range of -20.6 to 5.4)) and at T=1 was -5.1 g/l ±2SD (standard deviation of 24 (range of -29.1 to 18.9)) ( Table 2 ). The Figure 1 illustrates the markedly different standard deviations at the two timepoints. Of interest, 32% and 53% of average i-STAT ® Hb measurements had a difference of >±10 g/l compared to laboratory Hb at T=0 and T=1, respectively.
Bland-Altman plot in
The mean total plasma protein difference (total plasma protein T=0 minus T=1) was 13.6 g/l (95% confidence interval 10.2 to 17.0). This indicated that the patients recruited had a significant amount of blood loss with corresponding changes in total plasma protein. Spearman's correlation coefficients between the level of total plasma protein and the i-STAT ® minus laboratory Hb at T=0 and T=1 were not statistically significant (r=-0.09 and r=0.14, respectively). Spearman's correlation coefficients between the proportional changes in total plasma protein level and the i-STAT ® minus laboratory Hb at T=0 and T=1 were not statistically significant (r =-0.02 and r =-0.06, respectively).
DISCUSSION
i-STAT ® POCT had reasonable intra-patient precision (CV <3%). Even though the inaccuracy of i-STAT ® POCT pre-and post-blood loss was similar (-7.6 g/l at T=0 and -5.1 g/l at T=1), the i-STAT ® POCT had poor reliability with a large standard deviation after ≥25% TBV loss, meaning it could not be regarded as a sufficiently accurate measurement of Hb after significant blood loss.
The overall intra-patient precision of i-STAT ® POCT was consistent with past studies [9] [10] [11] [12] [13] [14] . Its precision is comparable to our institution's laboratory haematology analyser 19 . Even though this study was completed in 2007, the results remain clinically important and add to the information obtained from past studies.
The accuracy of the device was measured by comparing the mean difference between i-STAT ® Hb and laboratory-measured Hb, which was regarded as the reference standard. Of note, we did not test the accuracy of our laboratory-measured Hb. However, accuracy for the Sysmex XE-2100™ is determined by calibration against a commercial calibrator, which is provided by Sysmex every six months. Furthermore, the Sysmex XE-2100™ has been evaluated to be an accurate and precise analyser with a CV between 0 to 3.9% and r 2 of 1.0 19 .
We cannot directly compare the current study with past studies of the accuracy of the i-STAT ® POCT device as compared to laboratory-based analysers [6] [7] [8] [9] [10] [11] [12] [13] [14] . Some of these studies used least squares regression analysis and correlation coefficient, which is inappropriate for comparing two methods of measuring the same variable, as opposed to visualising T=0 is prior to blood loss; T=1 is after 25% blood loss. TBV=estimated total blood volume, Hb=haemoglobin, Lab=laboratory, SD=standard deviation.
the differences using a Bland-Altman analysis and testing the difference with an appropriate statistic such as limits of agreement [15] [16] . We had chosen to use laboratory Hb for the x-axis in the Bland-Altman plots as it is the reference standard in measuring Hb 16 .
Connelly et al found that "haematocrit adding", which is increasing i-STAT ® measured Hct by 1% pre-cardiopulmonary bypass (CPB) and 3% on CPB and post-CPB, resulted in the i-STAT ® -measured Hct to have acceptable accuracy as compared to laboratory calculated Hct (mean 0.52% with 1.42% standard deviation) 6 . The i-STAT ® manufacturer also recommends "haematocrit adjusting" using total plasma protein level to adjust the i-STAT ® -measured Hct. This resulted in acceptably accurate Hct measurement (mean 0.53% with 1.46% standard deviation). This study also indicated that plasma protein levels were a significant factor in ensuring an accurate i-STAT ® -measured Hct.
In addition, a laboratory-based study by Hopfer et al, which simulated haemodilution, found the i-STAT ® -measured Hct to be progressively lower than Coulter-derived Hct 7 . Haemodilution was achieved using different combinations of extracted plasma and red blood cells from anticoagulated whole blood with either saline or Ringer's diluent solutions. A discrepancy of 4% in Hct was found at the lowest simulated plasma protein levels. This study also found a negative bias to the i-STAT ® Hct value Figure 1 : Mean i-STAT ® Hb minus Lab Hb versus Lab Hb at T=0 (mean -7.6 g/l ± 2 standard deviations of 13 , range 5.4 and -20.6) and mean i-STAT ® Hb minus Lab Hb versus Lab Hb at T=1 (mean -5.1 g/l ± 2 standard deviations of 24, range 18.9 and -29.1). T=0 is prior to blood loss; T=1 is after 25% blood loss. Hb=haemoglobin, Lab=laboratory, SD=standard deviation.
between -12 g/l (range -57 to 28) and -15 g/l (range 18 to 24) with different saline and Ringer's diluent solutions, respectively. A study by Steinfelder-Visscher et al on a different conductometric-based Hct measuring device, the GEM ® Premier™ 3000, confirmed that there was a downward bias in Hct values below 30% 20 . McNulty et al also concluded that the Stat-Crit ® device, another conductometric-based Hct measuring device, was not as accurate as the photometric method 21 .
The accuracy and reliability of the i-STAT ® POCT device after ≥25% blood loss in our study was consistent with studies by Connelly et al 6 and Hopfer et al 7 . These studies, along with other conductometric Hct measuring devices studies, add to the evidence of the inaccuracy and unreliability of the i-STAT ® POCT device after major blood loss.
Our study found a poor correlation between the change in total plasma proteins and the inaccuracy of the i-STAT ® device despite studies on a POCT device using the conductometric method 6, 7, 20, 21 . If there was a correlation, the i-STAT ® device would have less accuracy as total plasma protein change increased.
There could be other reasons why such inaccuracies occur for the i-STAT ® POCT device despite it not being shown to correlate with total plasma protein.
A contributing factor could be the fact that nonlaboratory personnel performed the analyses under emergency clinical situations (at times of large amounts of blood loss). However, the device is designed for such circumstances and a study by Jacobs et al concluded that operator technique did not influence the accuracy or precision of the i-STAT ® device 9 . We did not investigate other variables that could cause the inaccuracy, such as total white blood cell count, plasma volume expanders, and lipid, sodium and potassium concentrations 1-2 .
We conclude that the i-STAT ® POCT is not sufficiently accurate (due to the wide standard deviations) and is unreliable when measuring Hb in patients with large blood losses. Clinicians should not use the i-STAT ® Hb in isolation for clinical decisionmaking when considering blood transfusion in a situation of 25% or greater blood loss.
